Xconomy National

Archives

by in

Entry	Author	Date	Location
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move	Luke Timmerman	11/08/10	Seattle
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline	Luke Timmerman	09/29/10	Seattle
Biotech Drug Discovery in Seattle: A Look Back	Stewart Lyman	06/11/10	Seattle
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News	Luke Timmerman	01/14/10	Seattle
Alder Rises from Ashes, Seattle Genetics Gets Empowered, ZymoGenetics Nets $79M & More Seattle-Area Life Sciences News	Luke Timmerman	01/07/10	Seattle
ZymoGenetics On the Prowl to Raise $85M in Stock Deal	Luke Timmerman	01/06/10	Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News	Luke Timmerman	12/24/09	Seattle
ZymoGenetics Regains Full U.S. Rights to Recothrom as Bayer Walks Away	Luke Timmerman	12/21/09	Seattle
Zymo Application Yanked in EU	Luke Timmerman	12/14/09	Seattle
ZymoGenetics Axes 52 Jobs, Quits Discovery of Immunology Drugs, to Conserve Cash	Luke Timmerman	12/03/09	Seattle
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding	Luke Timmerman	11/09/09	Seattle
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding	Luke Timmerman	10/26/09	Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News	Luke Timmerman	08/27/09	Seattle
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival	Luke Timmerman	08/20/09	Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety	Luke Timmerman	08/20/09	Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News	Luke Timmerman	08/06/09	Seattle
Zymo Gets $6M in Q2 Recothrom Sales	Luke Timmerman	08/03/09	Seattle
ZymoGenetics Drug Sales Still Slumping After Full Year on Market	Luke Timmerman	05/05/09	Seattle
ZymoGenetics Cuts One-Third of Workforce To Hold Onto Cash	Luke Timmerman	04/29/09	Seattle
ZymoGenetics Sales Chief Exits	Luke Timmerman	02/04/09	Seattle
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex	Luke Timmerman	01/05/09	Seattle
Blood News: A Quick Rundown of Headlines From the American Society of Hematology	Luke Timmerman	12/09/08	National
ZymoGenetics Drug For Surgical Bleeding Demonstrates Safety in Trial	Luke Timmerman	12/08/08	Seattle
ZymoGenetics Cash Gets Lean, Recothrom Sales Still Slow	Luke Timmerman	11/04/08	Seattle
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patients	Luke Timmerman	10/22/08	Seattle
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug	Luke Timmerman	09/08/08	Seattle
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval	Luke Timmerman	09/02/08	Seattle
ZymoGenetics Sells Land for $11.5 Million	Luke Timmerman	08/29/08	Seattle
ZymoGenetics Drug Getting Off to Slow Start in Marketplace	Luke Timmerman	08/06/08	Seattle
ZymoGenetics Receives $100 Million Commitment From Deerfield	Luke Timmerman	06/30/08	Seattle
Page 1 of 1